We have shown that low tissue iron protects from the initiation and progression of NASH in a dietary mouse model of the disease, and that many of the effects of iron may be exerted through TGF-β-dependent pathways. Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.